Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT01643902 · ClinicalTrials.gov registry record · Phase 2

Safety of Intravenous Thrombolytics in Stroke on Awakening

A Phase 2 study of Stroke, sponsored by Johns Hopkins University.

Completed
Registry status
Phase 2
Development phase
20
Enrollment target
2
Study locations

NCT01643902: Completed Phase 2 study of Stroke, sponsored by Johns Hopkins University.

NCT01643902 is a Phase 2 study of Stroke that has completed, run by Johns Hopkins University. The registered enrollment target is 20 participants, below the 12,016-participant average among 454 other Stroke trials with a reported enrollment target (100% lower). The trial reports 2 study locations across 1 state. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT01643902, a Phase 2 study of Stroke, has completed, sponsored by Johns Hopkins University.

COMPLETED
Registry status
Phase 2
Development phase
20 participants
Enrollment target
2
Study locations

Study Summary

The primary objective of this study is to evaluate the safety of intravenous tissue plasminogen activator (IV tPA) in patients waking up with symptoms of acute stroke and presenting to the Emergency Department (ED) within 4.5 hours from awakening, and meeting standard criteria for treatment with IV tPA for acute stroke. The hypothesis is that patients that wake up with stroke symptoms may have developed the stroke at the time of awakening, and may be within the 4.5 hour window if they arrive to the ED within that time, therefore IV tPA should be safe and effective in this population.

Conditions Studied

Stroke

Interventions

  • DRUG tPA

Study Locations (2)

Maryland

  • Johns Hopkins Bayview Medical Center - Baltimore
  • The Johns Hopkins Hospital - Baltimore

Trial Details

FieldValue
Enrollment Target 20 participants
Start Date 2013-01
Est. Completion 2015-12
Phase Phase 2

Sponsor

Johns Hopkins University

1,448 total trials

Interested in This Trial?

Full Details on ClinicalTrials.gov ↗

What the Registry Record Tells You About NCT01643902

The ClinicalTrials.gov registry entry for NCT01643902 describes a study currently listed as completed, categorized as Phase 2. The registered enrollment target is 20 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 12,016-participant average among 454 other Stroke trials with a reported enrollment target (100% lower). The listed sponsor is Johns Hopkins University, which has 1,448 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Stroke appearing as the primary indexed condition, and to 1 intervention - of which tPA is the first listed.

NCT01643902 reports 2 study locations spanning 1 distinct geographic area - top geographies include Maryland.

Frequently Asked Questions

What is clinical trial NCT01643902 about?

NCT01643902 is a clinical study titled "Safety of Intravenous Thrombolytics in Stroke on Awakening". The primary objective of this study is to evaluate the safety of intravenous tissue plasminogen activator (IV tPA) in patients waking up with symptoms of acute stroke and presenting to the Emergency Department (ED) within 4.5 hours from awakening, and meeting standard criteria for treatment with IV ...

What is the current status of trial NCT01643902?

This trial is currently completed. It is a Phase 2 study. The enrollment target is 20 participants. The study started on 2013-01. Estimated completion is 2015-12.

What conditions does trial NCT01643902 study?

This clinical trial studies the following conditions: Stroke.

What interventions are being tested in trial NCT01643902?

The interventions under investigation include: tPA (DRUG).

Who is sponsoring clinical trial NCT01643902?

This trial is sponsored by Johns Hopkins University, which has 1,448 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT01643902 being conducted?

This trial has 2 study locations across Maryland. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Learn More About Clinical Trials

Similar trials for Stroke

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Explore more on PlainTrial

Stroke

All registered trials for this condition

Maryland

All trials with a study site in Maryland

Recruiting now

Find trials open to new participants near you

Rankings

Top sponsors, conditions, and phases

Related

Compare this shortlist side-by-side

Read our methodology - how this data is sourced, computed, and verified.
Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.